Drug Class
monoclonal antibody VEGF inhibitor
Type
ingredient
Active Ingredient
bevacizumab
📋Overview
Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), a protein involved in the formation of new blood vessels. By inhibiting VEGF, it helps to restrict the blood supply to certain types of tumors. Bevacizumab is commonly associated with the management of various cancers, including colorectal, lung, and kidney cancers, as well as some eye conditions involving abnormal blood vessel growth.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Bevacizumab
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.